AuntMinnie

MARCH 7, 2024

In terms of 2023 spending, the average radiopharmaceutical expenditure per fixed PET site is estimated to be $517,000. In 2023, 38% of PET systems were operated by the PET department, 28% by nuclear medicine, 24% by radiology/imaging, 5% by radiation oncology, and 2% by molecular imaging.

PET Scan 115

PET Scan Nuclear Medicine Radiation Oncology Radiopharmaceuticals 115

Imaging Technology

MAY 23, 2023

milla1cf Tue, 05/23/2023 - 11:36 May 23, 2023 — More than 9 in 10 radiation oncologists report that their practices face clinical staff shortages , according to a new national survey from the American Society for Radiation Oncology ( ASTRO ). Radiation oncologists from across the country are in Washington, D.C.

Radiation Oncology 69

Radiation Oncology Radiation Clinic Medicare 69

TTG Imaging Solutions

OCTOBER 20, 2021

The American Society for Radiation Oncology 2021 Annual Meeting: October 24 – 26 TTG Imaging Solutions is proud to be exhibiting at the American Society for Radiation Oncology Annual Meeting in Chicago, IL. For the latest updates on TTG Imaging Solutions, connect with us on LinkedIn , Twitter , and Facebook.

Radiation Oncology 52

Radiation Oncology Imaging Radiopharmaceuticals Radiation 52

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

Imaging Technology

AUGUST 31, 2023

milla1cf Thu, 08/31/2023 - 15:50 August 31, 2023 — NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals, and Curadh MTR Inc. Ac-225 to Curadh for use in its pioneering molecularly targeted radiation (MTR) programs for the treatment of common lethal tumors. “We

Medical 91

Medical Radiopharmaceuticals Pharmaceutical Radiation 91

AuntMinnie

JUNE 20, 2024

F-18 fluorocholine (FCH) PET/CT could be a first-line technique over technetium-99m sestamibi (Tc-99m MIBI) SPECT/CT for imaging parathyroid tumors prior to surgery, according to a study published June 20 in JAMA Otolaryngology-Head & Neck Surgery. No complications occurred. The full study is available here.

Radiopharmaceuticals 105

Radiopharmaceuticals Radiation Imaging Clinic 105

Imaging Technology

JANUARY 12, 2024

Other technologies use anatomical images to guide radiotherapy delivery; however, SCINTIX therapy is the only radiotherapy to use emissions from cancer cells, created by injecting the patient with a radiopharmaceutical, to deliver a radiation dose that continuously and autonomously targets the cancer itself.

Radiopharmaceuticals 100

Radiopharmaceuticals Radiation Medicare Clinic 100

AuntMinnie

JANUARY 11, 2024

RefleXion said while other technologies use anatomical images to guide radiotherapy delivery, Scintix therapy is the only radiotherapy to use emissions from cancer cells. These are created by injecting the patient with a radiopharmaceutical to deliver a radiation dose that targets the cancer itself.

Radiopharmaceuticals 52

Radiopharmaceuticals Medicare Radiation Hospital 52

AuntMinnie

JUNE 14, 2024

Extravasations have never been required to be reported, NRC's senior health physicist Cindy Flannery said June 11 during a regulatory session at the Society of Nuclear Medicine and Molecular Imaging's (SNMMI) recent meeting in Toronto. That might do away with diagnostic concerns, Flannery noted.

Nuclear Medicine 52

Nuclear Medicine Radiation Radiopharmaceuticals Medical 52

TTG Imaging Solutions

MAY 5, 2023

Enhances TTG’s continued commitment to offer a full spectrum of high-quality and cost-effective service solutions in the cardiology and radiation oncology markets PITTSBURGH, PA (May 5, 2023) – TTG Imaging Solutions, LLC (TTG) announced today the acquisition of Digirad Health, Inc., headquartered in Suwanee, GA. Digirad Health, Inc.

Imaging 52

Imaging Radiopharmaceuticals Radiation Oncology Nuclear Medicine 52

AuntMinnie

MARCH 22, 2024

Data from theranostics is starting to focus on radiation dosimetry and dose limits in relation to kidney and other organ damage, said Nadine Mallak, MD, associate professor of body imaging and nuclear medicine at Oregon Health and Science University in Portland.

Nuclear Medicine 52

Nuclear Medicine Radiation Radiopharmaceuticals IT 52

Imaging Technology

AUGUST 29, 2023

Once securely attached to a targeting molecule, the chelated Cu-67 delivers therapeutic doses of radiation to destroy cancer cells with limited damage to healthy tissue. It supports a sustainable future for radiopharmaceuticals unencumbered by manufacturing, logistical and environmental issues inherent to many radiopharmaceuticals.

Pharmaceutical 75

Pharmaceutical Radiopharmaceuticals Clinic Medical 75

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

Imaging Technology

APRIL 2, 2024

announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio. There is also special focus on radiation therapy and Theranostics.

Healthcare 95

Healthcare Healthcare Radiation Oncology Magnetic Resonance Imaging 95

AuntMinnie

MARCH 25, 2024

PET/CT is poised to become a key tool for imaging the coronary arteries – a clinical imaging exam that can reveal early warning signs of fatal conditions when patients present with symptoms of chest pain, experts say. The game-changer could be the pending U.S. approval of new PET radiotracers, such as F-18 flurpiridaz , he said.

Nuclear Medicine 128

Nuclear Medicine Radiopharmaceuticals Disease Radiation 128

Imaging Technology

MAY 14, 2024

“University Hospitals shares its excitement in expanding its ongoing collaborative relationship with Siemens Healthineers, which has resulted in important improvements in magnetic resonance imaging. The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer's unique setting.

Hospital 103

Hospital Magnetic Resonance Imaging Radiopharmaceuticals Disease 103

Imaging Technology

JULY 5, 2023

Ac-225 is a high energy alpha-emitting radioisotope of increasing interest for clinical studies investigating the use of targeted radiopharmaceutical therapy, which combines select molecules with therapeutic radioisotopes to directly target and deliver therapeutic doses of radiation to destroy cancer cells in patients with serious disease.

Medical 63

Medical Radiopharmaceuticals Pharmaceutical Radiation 63

Future Teleradiology

NOVEMBER 27, 2023

This blog post sheds light on recent breakthroughs in nuclear medicine, illuminating the innovative advancements that are shaping the future of medical imaging and treatment. Discuss how these advancements enhance imaging capabilities, providing clearer insights into physiological processes.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Imaging Modalities Radiation 52

Imaging Technology

NOVEMBER 26, 2023

Radiopharmaceuticals are revolutionizing modern cancer treatment and precision dosimetry is a crucial component of this advanced therapy. This is already showing promise with several ongoing trials of approved and developmental radiopharmaceuticals.

Clinic 54

Clinic Radiopharmaceuticals Radiosensitivity Pharmaceutical 54

AuntMinnie

DECEMBER 7, 2023

Image courtesy of Business Wire. Przekop has over 35 years of experience in the nuclear pharmacy and radiopharmaceuticals industry, including commercial and operational experience in supply chain networks, marketing, and regulatory compliance oversight. Mark Przekop, COO, Nucleus RadioPharma.

Radiopharmaceuticals 59

Radiopharmaceuticals Radiation Oncology IT Imaging 59

AuntMinnie

APRIL 4, 2024

A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging.

Nuclear Medicine 86

Nuclear Medicine Radiation Oncology Nursing Radiation 86

Imaging Technology

MAY 30, 2023

milla1cf Tue, 05/30/2023 - 19:49 May 30, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals , today announced U.S. It is the first and only FDA-approved, PSMA-targeted imaging agent developed with proprietary radiohybrid (rh) technology.

Diagnostic 75

Diagnostic Imaging Radiopharmaceuticals Diagnostic Imaging 75

Imaging Technology

OCTOBER 18, 2023

About Targeted Alpha Therapy Targeted Alpha Therapy is an emerging class of cancer therapeutics, which seeks to deliver alpha radiation directly to the tumor while minimizing radiation exposure to normal tissue. Targeted radiopharmaceuticals are created by linking a therapeutic radioisotope to a targeting molecule (e.g.,

Radiopharmaceuticals 94

Radiopharmaceuticals Pharmaceutical Radiation Medical 94

Imaging Technology

SEPTEMBER 27, 2023

PET imaging with POSLUMA reveals clinical information crucial to decision-making for men with prostate cancer, and we are excited to share further information with the radiation oncology community at ASTRO 2023,” said David E. Jani, MD, FASTRO, Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Ga.,

Diagnostic 93

Diagnostic Radiation Oncology Radiation Clinic 93

Imaging Technology

AUGUST 23, 2023

SCINTIX therapy is a cutting-edge radiopharmaceutical-directed treatment applicable for early and late-stage cancers that uses the individual biology of each tumor to drive its own treatment. “We founder and CTO of RefleXion.

Radiopharmaceuticals 86

Radiopharmaceuticals Disease Radiation Clinic 86

TTG Imaging Solutions

AUGUST 10, 2023

Pete has over 20 years in the nuclear pharmacy industry and over 15 years in nuclear pharmacy management including expertise in logistics, complex supply chain management and radiopharmaceutical drug chemistry and formulation. Vice President, Pharmacy Operations appeared first on TTG Imaging Solutions.

Radiopharmaceuticals 40

Radiopharmaceuticals Radiation Imaging 40

Imaging Technology

JULY 28, 2023

It is the first and only FDA-approved, PSMA-targeted imaging agent developed with proprietary radiohybrid (rh) technology. Precision PET imaging with POSLUMA can help identify the location and extent of prostate cancer, providing clinically valuable information to guide patient management. POSLUMA was approved by the U.S.

Clinic 84

Clinic Diagnostic Radiopharmaceuticals Radiation 84

Imaging Technology

JULY 21, 2023

SCINTIX therapy, delivered by the RefleXion X1, uses emissions from cancer cells created by injecting the patient with a radiopharmaceutical to deliver a radiation dose that continuously and autonomously targets the cancer itself.

Radiopharmaceuticals 92

Radiopharmaceuticals Clinic Radiation Medical 92

Imaging Technology

OCTOBER 5, 2023

Specifically, this sub-group examined the performance of flotufolastat F 18 PET in newly diagnosed, high-risk prostate cancer patients who had negative results with conventional imaging. Kuo, MD, Ph.D. , Departments of Medical Imaging, Medicine, and Biomedical Engineering. Recently approved by the U.S. Gauden, D.Phil.

Diagnose 52

Diagnose Diagnostic Disease Radiation 52

AuntMinnie

JUNE 3, 2024

With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., Siegel told AuntMinnie.com. "My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

Imaging Technology

JULY 25, 2023

The ubiquitous expression of FAP in cancer-associated fibroblasts across nearly all epithelial-derived cancers paired with the low abundance in normal tissues, makes it a unique target to exploit for tumor imaging for a wide variety of cancers such as breast, pancreatic, lung and stomach cancer.

Radiopharmaceuticals 89

Radiopharmaceuticals Imaging Pharmaceutical Disease 89

Imaging Technology

JULY 11, 2023

The ubiquitous expression of FAP in cancer-associated fibroblasts across nearly all epithelial-derived cancers paired with the low abundance in normal tissues, makes it a unique target to exploit for tumor imaging for a wide variety of cancers such as breast, pancreatic, lung and stomach cancer.

Radiopharmaceuticals 70

Radiopharmaceuticals Imaging Pharmaceutical Disease 70

Imaging Technology

APRIL 3, 2023

produced, non-uranium based Mo-99 for use in diagnostic imaging. Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit.

Medical 82

Medical Radiopharmaceuticals Pharmaceutical Radiation 82

Imaging Technology

MAY 2, 2023

milla1cf Tue, 05/02/2023 - 23:50 May 2, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced additional results from its completed Phase 3 SPOTLIGHT trial of 18F-rhPSMA-7.3 PET imaging currently under review by the U.S.

Diagnostic 92

Diagnostic Radiopharmaceuticals Imaging Radiation 92

Imaging Technology

JUNE 29, 2023

milla1cf Thu, 06/29/2023 - 21:10 June 29, 2023 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced highlights from early clinical and preclinical studies of 177Lu-rhPSMA-10.1 higher tumor absorbed radiation dose.

Clinic 82

Clinic Nuclear Medicine Radiopharmaceuticals Radiation 82

Future Teleradiology

NOVEMBER 21, 2023

This blog explores the latest innovations in nuclear medicine, shedding light on cutting-edge technologies and breakthroughs that are reshaping the landscape of medical imaging and treatment. Revolutionizing Imaging with Hybrid PET/CT and PET/MRI: Explore the integration of hybrid imaging technologies.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Teleradiology 52

Imaging Technology

AUGUST 30, 2023

The study was published in the International Journal of Radiation Oncology, Biology, Physics. FLASH is an experimental mode of delivering radiation therapy for cancer that can be delivered to a patient in less than one second and which can be over 100 times faster than conventional radiation therapy.

Radiation Oncology 95

Radiation Oncology Radiation Radiopharmaceuticals Clinic 95